Pfizer, under its competitive grant programme, invites applications for its ASPIRE global cachexia grant. This supports research to gain a better understanding of the relationship between cachexia and cancer or heart failure. Basic science, preclinical research, and clinical research, animal experimentation related to human biology, and translational studies in the following topics will be considered:
•evidence generation in understanding cachexia in cancer or heart failure;
•the role of GDF-15/GFRAL pathway in disease;
•GDF-15/GFRAL biology; and
•natural history or longitudinal studies specifically related to cachexia or heart failure.
Applicant PI’s must have a medical or postdoctoral degree, an advanced nursing degree or a degree in pharmacy, physiotherapy, or social work and must be affiliated with a host institution.
Grants are worth up to USD 250,000 for up to three years.
Deadline: 7th January 2021.